Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

4.4K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.4K
Bone Disorders01:29

Bone Disorders

5.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.7K
Bone Remodeling01:40

Bone Remodeling

40.7K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.7K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

4.0K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.0K
What is the Skeletal System?01:02

What is the Skeletal System?

58.1K
Overview
58.1K
Fractures: Bone Repair01:27

Fractures: Bone Repair

6.0K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Staphylococcus aureus</i> inhibits the NLRP3 inflammasome in macrophages to varying degrees during early and late stages of infection.

Infection and immunity·2026
Same author

Loss of Progranulin Expression Decreases NLRP3 Inflammasome-Mediated Inflammation and Enhances Bone Anabolism.

Research square·2026
Same author

Activation of the NLRP3 inflammasome in osteoclasts is suppressed by a Tmem178-dependent mechanism that restricts Ca<sup>2+</sup> influx.

Science signaling·2026
Same author

The osteoclast intracellular environment fosters bacterial growth during <i>Staphylococcus aureus</i> infection.

bioRxiv : the preprint server for biology·2026
Same author

A novel murine model of early calcium pyrophosphate deposition disease based on the TNFRSF11B mutation mimics features of the human disease.

Annals of the rheumatic diseases·2026
Same author

MyD88 signaling in myeloid cells induces gastrointestinal tract injury and systemic inflammation after West Nile virus infection.

Cell reports·2026
Same journal

Extracellular matrix reprogramming by the YAP/TAZ- TGF-ß2 axis drives immune exclusion in cholangiocarcinoma models.

The Journal of clinical investigation·2026
Same journal

Tumor cell-derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancer.

The Journal of clinical investigation·2026
Same journal

Julie Zikherman receives the ASCI/Marian W. Ropes, MD, Award.

The Journal of clinical investigation·2026
Same journal

Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma models.

The Journal of clinical investigation·2026
Same journal

SGLT2 inhibitors enhance ketogenesis by acting as allosteric activators of the mitochondrial enzyme HMGCS2.

The Journal of clinical investigation·2026
Same journal

MDM2 degraders for Merkel cell carcinoma: round peg in a round hole.

The Journal of clinical investigation·2026
See all related articles

Related Experiment Video

Updated: Mar 1, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

12.2K

Inflammatory osteolysis: a conspiracy against bone.

Gabriel Mbalaviele1, Deborah V Novack1,2, Georg Schett3

  • 1Department of Medicine, Division of Bone and Mineral Diseases, and.

The Journal of Clinical Investigation
|June 2, 2017
PubMed
Summary
This summary is machine-generated.

Inflammatory osteolysis involves bone-degrading osteoclasts. New insights into inflammasomes are needed to improve treatments for inflammatory arthritis and bone damage.

More Related Videos

Construction and Evaluation of a Murine Calvarial Osteolysis Model by Exposure to CoCrMo Particles in Aseptic Loosening
09:46

Construction and Evaluation of a Murine Calvarial Osteolysis Model by Exposure to CoCrMo Particles in Aseptic Loosening

Published on: February 17, 2018

9.0K
A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

7.5K

Related Experiment Videos

Last Updated: Mar 1, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

12.2K
Construction and Evaluation of a Murine Calvarial Osteolysis Model by Exposure to CoCrMo Particles in Aseptic Loosening
09:46

Construction and Evaluation of a Murine Calvarial Osteolysis Model by Exposure to CoCrMo Particles in Aseptic Loosening

Published on: February 17, 2018

9.0K
A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

7.5K

Area of Science:

  • Bone biology and immunology
  • Inflammatory diseases
  • Osteoclast differentiation and function

Background:

  • Inflammatory osteolysis, characterized by bone degradation, is primarily mediated by osteoclasts.
  • Therapies targeting inflammatory cytokines and osteoclast activity have advanced treatment but leave many patients resistant.
  • Current treatments often fail to repair bone damage caused by inflammatory arthritis.

Purpose of the Study:

  • To explore the role of inflammasomes in inflammatory osteolysis.
  • To identify novel therapeutic targets beyond cytokine-dependent mechanisms.
  • To enhance treatment strategies for inflammatory arthritis-related bone loss.

Main Methods:

  • Review of current literature on osteoclast biology and inflammatory pathways.
  • Analysis of inflammasome signaling in the context of bone metabolism.
  • Investigation of cytokine-dependent and -independent mechanisms in osteolysis.

Main Results:

  • Osteoclasts are central to bone degradation in inflammatory osteolysis.
  • Existing therapies targeting cytokines and osteoclasts show limitations in efficacy and bone repair.
  • Inflammasomes represent a critical signaling pathway influencing osteolysis through diverse mechanisms.

Conclusions:

  • Understanding inflammasome signaling is crucial for optimizing inflammatory osteolysis treatment.
  • Novel therapeutic approaches may need to address both cytokine-dependent and -independent pathways.
  • Further research into inflammasomes could lead to improved bone repair in inflammatory conditions.